Results 141 to 150 of about 13,171 (198)

Species-specific gB ectodomain interactions and cytoplasmic domain stability regulate herpes simplex virus fusion. [PDF]

mBio
Fan Q, Longnecker R, Connolly SA.
europepmc   +1 more source

Immune checkpoint-based biomarkers for therapeutic response in patients with multiple sclerosis. [PDF]

Front Immunol
López-Molina M, Torres Iglesias G, Sáenz de Santa María-Diez G, Valentín-Quiroga J, Laso-García F, Gallego R, Pozo-Novoa J, Chamorro B, López-Collazo E, Puertas I, Díez-Tejedor E, Gutiérrez-Fernández M, Otero-Ortega L.   +12 more
europepmc   +1 more source

Immune landscape of gingivo-buccal oral cancer indicates high enrichment of immune-related gene sets in tumors of a large proportion of patients. [PDF]

Mol Med
Das D, Maitra A, Panda CK, Ghose S, Roy B, Sarin R, Majumder PP.   +6 more
europepmc   +1 more source

Genetically determined causality between immune cells and anxiety disorders: A Mendelian randomization study. [PDF]

Medicine (Baltimore)
Liu J, Liang P, Wang Y, Huang H, Zhang S, Li G, Wu H.   +6 more
europepmc   +1 more source

Immune Cell Causality and Glucocorticoid Trade-Off in Frozen Shoulder: Integrative MR-RNA-Seq Analysis. [PDF]

Biomedicines
Song B, Zhan Z, Gao H, Che H, Hao Y, Li Y, Hu D.   +6 more
europepmc   +1 more source

Immune checkpoints in immune response to glioma: two sides of the same coin. [PDF]

Front Immunol
Musatova O, Kumar V, Vinogradov K, Rubtsov Y.   +3 more
europepmc   +1 more source

Blockade of HVEM for Prostate Cancer Immunotherapy in Humanized Mice

Cancers, 2021
International audienceThe herpes virus entry mediator (HVEM) delivers a negative signal to T cells mainly through the B and T lymphocyte attenuator (BTLA) molecule.
Daniel Olive, Nicolas Aubert, Gilles Marodon   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

HVEM-derived peptides as inhibitors of HVEM/LIGHT complex formation

Bioorganic Chemistry
T cells are important targets for therapeutic intervention in many diseases. Modifying T cell activation via immune checkpoints plays a central role in such approaches. The HVEM/LIGHT complex is one of the stimulatory immune checkpoints involved in T cell activation, and binding of these proteins results in proliferation and development of effector ...
Piotr Ciura, Simon Gumpelmair, Emilia Sikorska, Sylwia Rodziewicz-Motowidło, Peter Steinberger, Marta Spodzieja, Adam Sieradzan   +6 more
openaire   +3 more sources

Hvem får, og hvem får ikke en Nobelpris?

Samfundsøkonomen, 2017
Det er fristende at søge et mønster i tildelingerne af Nobelprisen i økonomi over de knap 50 år, hvor den har været uddelt, men udover ret oplagte mønstre som et timelag på 30 år fra den forskning, der indgår i begrundelsen, til den faktiske tildeling, er det svært at aflæse nogen systematik.
Nanna Fink, Hans Keiding
openaire   +1 more source

HVEM network signaling in cancer

2019
Somatic mutations in cancer cells may influence tumor growth, survival, or immune interactions in their microenvironment. The tumor necrosis factor receptor family member HVEM (TNFRSF14) is frequently mutated in cancers and has been attributed a tumor suppressive role in some cancer contexts.
John R, Šedý, Parham, Ramezani-Rad
openaire   +2 more sources